Mark O'Neil-Johnson
Corporate Officer/Principal bei Sequoia Sciences, Inc.
Profil
Mark O'Neil-Johnson is currently working as Vice President-Analytical Chemistry at Sequoia Sciences, Inc. Prior to this, he worked as Principal at International Business Machines Corp., the University of California, Berkeley, IBM Research, and Bruker Instruments, Inc.
Aktive Positionen von Mark O'Neil-Johnson
| Unternehmen | Position | Beginn |
|---|---|---|
Sequoia Sciences, Inc.
 Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Sequoia Sciences, Inc. engages in the development of new medicines for the treatment of bacterial infections and cancers. The firm's development programs consist of small molecules targeting bacterial infections and cancers, and vaccines for the treatment and prevention of recurrent urinary tract infections. The company was founded by Gary R. Eldridge, Jr. in 1999 and is headquartered in St. Louis, MO. | Corporate Officer/Principal | - |
Ehemalige bekannte Positionen von Mark O'Neil-Johnson
| Unternehmen | Position | Ende |
|---|---|---|
| Bruker Instruments, Inc. | Corporate Officer/Principal | - |
IBM Research
 IBM Research Miscellaneous Commercial ServicesCommercial Services Part of International Business Machines Corp., IBM Research is a corporate research lab with over 3,000 researchers in 19 locations across six continents. The company is based in Yorktown Heights, NY and was founded by Thomas Boudalier. The company invests in breakthroughs such as artificial intelligence, quantum computing, and blockchain technology. IBM Research is dedicated to applying AI and science to industry challenges, from healthcare to environmentalism to retail. | Corporate Officer/Principal | - |
| IBM | Corporate Officer/Principal | - |
| University of California, Berkeley | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| IBM | Technology Services |
| Private Unternehmen | 3 |
|---|---|
Sequoia Sciences, Inc.
Sequoia Sciences, Inc. Pharmaceuticals: OtherHealth Technology Sequoia Sciences, Inc. engages in the development of new medicines for the treatment of bacterial infections and cancers. The firm's development programs consist of small molecules targeting bacterial infections and cancers, and vaccines for the treatment and prevention of recurrent urinary tract infections. The company was founded by Gary R. Eldridge, Jr. in 1999 and is headquartered in St. Louis, MO. | Health Technology |
IBM Research
IBM Research Miscellaneous Commercial ServicesCommercial Services Part of International Business Machines Corp., IBM Research is a corporate research lab with over 3,000 researchers in 19 locations across six continents. The company is based in Yorktown Heights, NY and was founded by Thomas Boudalier. The company invests in breakthroughs such as artificial intelligence, quantum computing, and blockchain technology. IBM Research is dedicated to applying AI and science to industry challenges, from healthcare to environmentalism to retail. | Commercial Services |
| Bruker Instruments, Inc. |
